[1]NIE QH.Clinical practice of antiviral treatment for liver cirrhosis patients with chronic hepatitis B[J].Chin J Pract Intern Med,2014,34(6):568-571.(in Chinese)聂青和.核苷酸类似物药物治疗乙型肝炎肝硬化的临床实践[J].中国实用内科杂志,2014,34(6):568-571.
|
[2]FENG HL,LI Q,WANG L,et al.Indocyanine green clearance test combined with MELD score in predicting the short-term prognosis of patients with acute liver failure[J].Hepatobiliary Pancreat Dis Int,2014,13(3):271-275.
|
[3]LIU YR,FANG ZP,YANG W,et al.Clinical evaluation of liver storage function by indocyanine green retention test[J].Chin J Hepatol,2010,18(6):476-477.(in Chinese)刘义荣,范作鹏,杨薇,等.吲哚菁绿滞留测试对肝储备功能的评价[J].中华肝脏病杂志,2010,18(6):476-477.
|
[4] Chinese Society of Hepatology,Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B(2010 version)[J].J Chin J Intern Med,2011,50(2):168-179.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010版)[J].中华内科杂志,2011,50(2):168-179.
|
[5]FUNG J,POON RT,YU WC,et al.Use of liver stiffness measurement for liver resection surgery:correlation with indocyanine green clearance testing and post-operative outcome[J].PLoS One,2013,8(8):e72306.
|
[6]MULLIN EJ,METCALFE MS,MADDERN GJ.How much liver resection is too much?[J].Am J Surg,2005,190(1):87-97.
|
[7] DONG JH,ZHENG SS,CHEN XP,et al.Consensus on evaluation of hepatic functional reserve before hepatectomy(2011 version)[J].Chin J Dig Surg,2011,10(1):20-25.(in Chinese)董家鸿,郑树森,陈孝平,等.肝切除术前肝脏储备功能评估的专家共识(2011版)[J].中华消化外科杂志,2011,10(1):20-25.
|
[8]KAMEI H,FUJIMOTO Y,NAGAI S,et al.Impact of non-congestive graft size in living donor liver transplantation:new indicator for additional vein reconstruction in right liver graft[J].Liver Transpl,2007,13(9):1295-1301.
|
[9]PAN Z,WU XJ,LI JS,et al.Functional hepatic flow in patients with liver cirrhosis[J].World J Gastroenterol,2004,10(6):915-918.
|
[10]CHENG XP,ZHAO J,CHEN Y,et al.Comparison of the ability of the PDD-ICG clearance test,CTP,MELD,and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis[J].Eur J Gastroenterol Hepatol,2016,28(4):444-448.
|
[11]SHENG QS,LANG R,HE Q,et al.Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis[J].Hepatobiliary Pancreat Dis Int,2009,8(1):46-49.
|
[12]CRDENAS A,GINS P.Predicting mortality in cirrhosis--serum sodium helps[J].N Engl J Med,2008,359(10):1060-1062.
|
[13]ZIPPRICH A,KUSS O,ROGOWSKI S,et al.Incorporating indocyanin green clearance into the Model for End Stage Liver Disease(MELD-ICG)improves prognostic accuracy in intermediate to advanced cirrhosis[J].Gut,2010,59(7):963-968.
|
[14]NI LD,HU F,CHENG ML,et al.Prognostic value of MELD-1CG in HBV/HCV cirrhosis:a prospective study[J].Chin Hepatol,2013,18(7):439-443.(in Chinese)倪鎏达,胡峰,程明亮,等.MELD-ICG对HBV/HCV肝硬化预后的评估价值[J].肝脏,2013,18(7):439-443.
|
[15]GUPTA S,CHAWLA Y,KAUR J,et al.Indocyanine green clearance test(using spectrophotometry)and its correlation with model for end stage liver disease(MELD)score in Indian patients with cirrhosis of liver[J].Trop Gastroenterol,2012,33(2):129-134.
|